Equities

Definitive Healthcare Corp

DH:NSQ

Definitive Healthcare Corp

Actions
TechnologyTechnology
  • Price (USD)4.57
  • Today's Change0.17 / 3.86%
  • Shares traded735.55k
  • 1 Year change-36.35%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Definitive Healthcare Corp had net income fall 2,702.38% from a loss of 7.22m to a larger loss of 202.39m despite revenues that grew 12.92% from 222.65m to 251.42m over the same period.
Gross margin79.46%
Net profit margin-203.28%
Operating margin-242.86%
Return on assets-34.66%
Return on equity-53.19%
Return on investment-47.79%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Definitive Healthcare Corp fell by 15.96m. However, the company earned 41.19m from its operations for a Cash Flow Margin of 16.38%. In addition the company used 31.78m on investing activities and also paid 25.58m in financing cash flows.
Cash flow per share-4.00
Price/Cash flow per share--
Book value per share3.27
Tangible book value per share-1.80
More ▼

Balance sheet in USDView more

Definitive Healthcare Corp has a Debt to Total Capital ratio of 26.16%, a lower figure than the previous year's 28.48%.
Current ratio2.49
Quick ratio--
Total debt/total equity0.4865
Total debt/total capital0.2616
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.